ARBs for cardiovascular and renal protection in high-risk patients.
Cardiovasc J Afr, 2011/7-2011/8;22(4):224.
PMID: 21881697
Impact factor: 0.802
MeSH terms
Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney Diseases; Male; Ramipril; Risk Assessment; Risk Factors; Telmisartan; Treatment Outcome
More resources
EndNote: Download